January 9, 2012
BerGenBio AS, a Bergen, Norway-based oncology biopharma company, has completed an $8.8m Series A financing round. The round was led by Sarsia Seed AS and Investinor AS. The funding will be used primarily to take lead compound BGB324 – an inhibitor of AXL kinase – into clinical trials and to develop a companion diagnostic. Led [...]
Read more →
July 6, 2011
poLight AS, a Horten, south of Oslo, Norway-based developer of micro-optics components, closed a NOK100m ($18.5m) Series B financing round. The round was led by Investinor, with participation from existing shareholders Viking Venture III AS, Alliance Venture Polaris AS and SINTEF Venture III AS. This financing could be extended to NOK130m ($24.5m) in the second [...]
Read more →
